Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen ...

He served as CEO of Catalent from 2009 to 2015, then as Chair and CEO from 2016 through 2022, and as Executive Chair until June 2023. Under his leadership, Catalent grew into a global Tier 1 CDMO ...

He served as CEO of Catalent from 2009 to 2015 ... EW healthcare Partners that contributed its portfolio company, ABL, Inc. in late 2024, Ascend offers expanded commercial manufacturing, process ...

John Chiminski brings more than three decades of leadership in healthcare and pharma services. He served as CEO of Catalent from 2009 to 2015, then as Chair and CEO from 2016 through 2022, and as ...

Jupiter Neurosciences (JUNS) announced a strategic partnership with Aquanova to jointly develop a series of consumer-focused nutritional ...

Eli Lilly has called on financial regulators to look into the antitrust implications of Novo Holdings' purchase of Catalent and the sale of three manufacturing facilities to Novo Nordisk.

The transaction – first announced in February – would see Novo Nordisk's parent company Novo Holdings buy contract development and manufacturing organisation (CDMO) Catalent outright for $16.5 ...

What's a great business idea without a great business name? This AI tool helps create brandable names for you.

Call it providential housing: a joint venture by Logos Faith Development and Cal Lutheran Homes to build apartments in Los ...

Discover how startups leverage AI-driven tools for cost-effective, high-quality visual branding—creating logos, marketing assets, ...